Squarex Pharmaceutical Corp — Form D

Squarex Pharmaceutical Corp of SAINT PAUL, MN, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-22. The offering totals $2.0M, of which $25K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2022-11-22
• Form: D
• Accession: 0001493152-22-033378
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $2.0M
• Amount sold: $25K
• Remaining: $2.0M
• Minimum investment: $25K
• Investors: 1
• Date of first sale: 2022-10-24
• Revenue range: No Revenues
• SEC file number: 021-465666

Issuer

• Name: Squarex Pharmaceutical Corp
• CIK: 0001864607
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 1000 WESTGATE DRIVE, SUITE 1010, SAINT PAUL, MN, 55114
• Phone: 651-207-8270

Officers, directors & promoters (3)

More

• CIK 1864607 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search